Regulatory Developments Banner Image

Regulatory Developments

Follow Blog Via Email:

Filter Content By:

Axing the Faxing, Medicare Advantage Plans, and Pharmacist Reimbursements

January 18, 2023

For more information about this blog post, please contact Khaled J. Klele, Ryan M. Magee, Ryan L. O’Neill, Connor Breza, William...

HIPAA Part 2 and Price Transparency Update

January 13, 2023

For more information about this blog post, please contact Khaled J. Klele, Ryan M. Magee, Ryan L. O’Neill, Connor Breza, William R. Meiselas or Labinot...

Extension of Waivers, Including Telehealth, and Proposed OPIOID Treatment Rules

January 10, 2023

For more information about this blog post, please contact Khaled J. Klele, Ryan M. Magee, Ryan L. O’Neill, Connor Breza, William...

Good Faith Estimate Extension and HIPAA Update

December 20, 2022

For more information about this blog post, please contact Khaled J. Klele, Ryan M. Magee, Ryan L. O’Neill, Connor Breza, William...

Prior Authorizations, 340B, and a National Provider Directory

December 14, 2022

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. CMS Proposes...

New Guidelines on Pain Management, HIPAA Update and the Family Fix

December 7, 2022

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. CDC Issues New Guidelines...

Bad Debt Under the False Claims Act and the FTC’s New Policy Statement

November 30, 2022

For more information about this blog post, please contact Ryan L. O’Neill  or Labinot Alexander Berlajolli. Federal Case...

Four Final Payment Rules Issued by CMS

November 10, 2022

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. The United States Centers...

CMS Enhancing Oversight of Poor Performing Nursing Homes

October 26, 2022

For more information about this blog post, please contact  Ryan L. O’Neill or Labinot Alexander Berlajolli. The Centers...

Behavioral Health Integration, 340B Litigation, and Medicare Advantage Plans

October 13, 2022

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. HHS Releases...

New Jersey Regulatory Update Part 5

September 28, 2022

This fifth entry to our 2022 Regulatory Update further reviews regulatory changes published this year through the...

New Jersey Regulatory Update: Part 4

September 19, 2022

Part 4 of our Regulatory Update focuses on vaccine administration, expanding who can prescribe Narcan, among others....

Get Our Latest Insights

Subscribe